Erschienen in:
01.11.2002 | Adis New Drug Profile
Aripiprazole
A Viewpoint by Atsuko Inoue
verfasst von:
Atsuko Inoue
Erschienen in:
CNS Drugs
|
Ausgabe 11/2002
Einloggen, um Zugang zu erhalten
Excerpt
Aripiprazole, a quinolinone derivative, is a dopaminergic agent developed as an antipsychotic drug for the treatment of schizophrenia. Aripiprazole ameliorates not only the positive symptoms but also the negative symptoms of schizophrenia, with reduced extrapyramidal and endocrine adverse effects relative to some other drugs such as haloperidol. …